Predicting toxicity in radiotherapy for prostate cancer.

Published on Mar 1, 2016in Physica Medica2.485
· DOI :10.1016/J.EJMP.2016.03.003
Valeria Landoni20
Estimated H-index: 20
,
Claudio Fiorino54
Estimated H-index: 54
+ 3 AuthorsTiziana Rancati27
Estimated H-index: 27
Sources
Abstract
Abstract This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009). The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose–volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review. A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (
📖 Papers frequently viewed together
332 Citations
626 Citations
87 Citations
References85
Newest
#1Cesare CozzariniH-Index: 43
#2Tiziana RancatiH-Index: 27
Last. Claudio FiorinoH-Index: 54
view all 11 authors...
Aim To assess the predictors of the onset of impotence 1 year after radiotherapy for prostate cancer.
5 CitationsSource
#1Federica PaloriniH-Index: 11
#2Cesare CozzariniH-Index: 43
Last. Claudio FiorinoH-Index: 54
view all 9 authors...
Abstract Purpose To develop a method for investigating local dose effects on the bladder after prostate cancer radiotherapy based on dose–surface maps (DSMs). Background and purpose DSMs of patients included in a prospective study (DUE01) were generated by virtually cutting bladder contours at the points intersecting the sagittal plane passing through its center-of-mass: maps were laterally normalized and aligned at the posterior inferior point. The average DSMs of patients with/without toxicity...
36 CitationsSource
#1Carla SiniH-Index: 9
#2C. FiorinoH-Index: 7
Last. Cesare CozzariniH-Index: 43
view all 12 authors...
Abstract Purpose To prospectively identify clinical/dosimetric predictors of acute/late hematologic toxicity (HT) in chemo-naIve patients treated with whole-pelvis radiotherapy (WPRT) for prostate cancer. Material and methods Data of 121 patients treated with adjuvant/salvage WPRT were analyzed (static-field IMRT n =19; VMAT/Rapidarc n =57; Tomotherapy n =45). Pelvic bone marrow (BM) was delineated as ilium (IL), lumbosacral, lower and whole pelvis (WP), and the relative DVHs were calculated. HT...
24 CitationsSource
#1Federica PaloriniH-Index: 11
#2Tiziana RancatiH-Index: 27
Last. C. FiorinoH-Index: 7
view all 20 authors...
Abstract Purpose/objective Prospectively assessing clinical/dosimetry factors affecting the acute worsening of urinary functionality after radiotherapy for prostate cancer. Material/methods DUE01 population was considered, including patients treated with conventional or moderate hypo-fractionation (2.2–2.7Gy/fr). Relevant clinical factors were collected, urinary symptoms were self-reported through the International Prostate Symptom Score (IPSS) before and at the end of radiotherapy; while absolu...
16 CitationsSource
#1Ruud C. Wortel (EUR: Erasmus University Rotterdam)H-Index: 8
#2Marnix G. Witte (NKI-AVL: Netherlands Cancer Institute)H-Index: 18
Last. Wilma D. Heemsbergen (NKI-AVL: Netherlands Cancer Institute)H-Index: 29
view all 8 authors...
Abstract Background and purpose We evaluated dose distributions in the anorectum and its relation to acute gastrointestinal toxicities using dose surface maps in an image-guided (IG) IMRT and 3D-conformal radiotherapy (3D-CRT) population. Material and methods For patients treated to 78Gy with IG-IMRT ( n =260) or 3D-CRT ( n =215), for whom acute toxicity data were available, three types of surface maps were calculated: (1) total anorectum using regular intervals along a central axis with perpend...
48 CitationsSource
#1Maria Thor (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 16
#2Caroline Olsson (University of Gothenburg)H-Index: 12
Last. Joseph O. Deasy (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 63
view all 12 authors...
ABSTRACTBackground. Gastrointestinal (GI) morbidity after radiotherapy (RT) for prostate cancer is typically addressed by studying specific single symptoms. The aim of this study was to explore the interplay between domains of patient- reported outcomes (PROs) on GI morbidity, and to what extent these are explained by RT dose to the GI tract.Material and methods. The study included men from two Scandinavian studies (N = 211/277) who had undergone primary external beam radiotherapy (EBRT) for loc...
26 CitationsSource
#1Cesare CozzariniH-Index: 43
#2Tiziana RancatiH-Index: 27
Last. C. FiorinoH-Index: 7
view all 14 authors...
Abstract Purpose A prospective trial started in 2010, aiming at developing models for urinary toxicity and erectile dysfunction after radiotherapy for prostate cancer. This analysis is finalised at highlighting correlations between clinical/dosimetric factors and acute urinary specific symptoms, as measured by single questions of the International Prostate Symptom Score (IPSS). Materials/methods IPSS was prospectively collected before and at the end of radiotherapy; absolute weekly bladder dose–...
19 CitationsSource
#1Noorazrul Azmie Yahya (UWA: University of Western Australia)H-Index: 7
#1Noorazrul Azmie Yahya (UWA: University of Western Australia)H-Index: 5
Last. James W. Denham (University of Newcastle)H-Index: 56
view all 7 authors...
Abstract Purpose/objective To identify dosimetry, clinical factors and medication intake impacting urinary symptoms after prostate radiotherapy. Material and methods Data describing clinical factors and bladder dosimetry (reduced with principal component (PC) analysis) for 754 patients treated with external beam radiotherapy accrued by TROG 03.04 RADAR prostate radiotherapy trial were available for analysis. Urinary symptoms (frequency, incontinence, dysuria and haematuria) were prospectively as...
24 CitationsSource
#1Valérie Fonteyne (Ghent University Hospital)H-Index: 27
#2Simin Sadeghi (Ghent University Hospital)H-Index: 3
Last. Gert De Meerleer (Ghent University Hospital)H-Index: 36
view all 7 authors...
AbstractBackground. External beam radiotherapy is an excellent treatment for patients with prostate cancer (PC). Assessing long-term radiotherapy-induced toxicity is important. We evaluated the impact of implementing different rectal dose volume constraints (DVC) on late rectal and urinary toxicity.Material and methods. Six hundred and thirty-seven PC patients were treated with high-dose intensity-modulated radiotherapy (IMRT) in the primary (median dose of 78 Gy to the prostate) or postoperativ...
8 CitationsSource
#1Vittoria D’AvinoH-Index: 13
#2Giuseppe De PalmaH-Index: 31
Last. Laura CellaH-Index: 25
view all 8 authors...
Background Gastrointestinal (GI) toxicity is a common effect following radiation therapy (RT) for prostate cancer. Purpose of the present work is to compare two Normal Tissue Complication Probability (NTCP) modelling approaches for prediction of late radio-induced GI toxicity after prostate external beam radiotherapy.
12 CitationsSource
Cited By49
Newest
#1Fernando Munoz (AUSL: Academy for Urban School Leadership)H-Index: 11
#2Giuseppe SanguinetiH-Index: 37
Last. A. FaiellaH-Index: 5
view all 0 authors...
Background: Baseline urinary incontinence (UI) strongly modulates UI recovery after adjuvant/salvage radiotherapy (ART/SRT), inducing clinicians to postpone it “as much as possible”, maximizing UI recovery but possibly reducing efficacy. This series aims to analyze the trend of UI recovery and its predictors at radiotherapy start. Methods: A population of 408 patients treated with ART/SRT enrolled in a cohort study (ClinicalTrials.gov #NCT02803086) aimed at developing predictive models of radiat...
Source
Source
#1Soumyajit Roy (U of O: University of Ottawa)H-Index: 11
#1Soumyajit Roy (U of O: University of Ottawa)H-Index: 1
Last. Shawn Malone (U of O: University of Ottawa)H-Index: 29
view all 9 authors...
Abstract Purpose The impact of treating physician on radiation therapy (RT) related toxicity is unclear. We carried out a secondary analysis of a randomized controlled study to determine whether the risk of RT–related late toxicities in patients with prostate cancer varies depending on the treating radiation oncologist. Methods and Materials This is a secondary analysis of a phase 3 randomized controlled study in which patients with prostate cancer with Gleason score ≤7, clinical stage T1b-T3a, ...
Source
Abstract Purpose To estimate the Lyman Kutcher Burman (LKB) and multivariate NTCP models predicting the AUT of prostate cancer treated with CIRT. Materials and Methods A cohort of 154 prostate adenocarcinoma patients were retrospectively analyzed. The AUT levels were graded according to CTCAE 4.03. Based on dosimetric parameters and/or clinical factors, a set of variables with best-fit values determined in the two models was validated by the area under the receiver operating characteristic curve...
Source
#1Andrea BresolinH-Index: 1
#2A. FaiellaH-Index: 5
Last. Cesare CozzariniH-Index: 43
view all 24 authors...
Abstract Background and purpose To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Materials and methods Complete data of 415 patients enrolled in a multi institute, prospective trial (#NCT02803086) treated with radical (31%), adjuvant (33%) and salvage (36%) intent at a median dose to pelvic nodes/lymph-nodal area of 53Gy were available. The most severe change...
Source
#1Stefania ZupponeH-Index: 3
#2Andrea BresolinH-Index: 1
Last. Cesare CozzariniH-Index: 43
view all 14 authors...
Despite the dramatic advancements in pelvic radiotherapy, urinary toxicity remains a significant side-effect. The assessment of clinico-dosimetric predictors of radiation cystitis (RC) based on clinical data has improved substantially over the last decade; however, a thorough understanding of the physiopathogenetic mechanisms underlying the onset of RC, with its variegated acute and late urinary symptoms, is still largely lacking, and data from pre-clinical research is still limited. The aim of ...
1 CitationsSource
#1Michela Carlotta Massi (Polytechnic University of Milan)H-Index: 2
#2Francesca Gasperoni (Medical Research Council)
Last. Tiziana RancatiH-Index: 27
view all 46 authors...
Background: REQUITE (validating pREdictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve QUalITy of lifE in cancer survivors) is an international prospective cohort study. The purpose of this project was to analyse a cohort of patients recruited into REQUITE using a deep learning algorithm to identify patient-specific features associated with the development of toxicity, and test the approach by attempting to validate previously published genetic risk factors....
2 CitationsSource
#1Thyrza Jagt (EUR: Erasmus University Rotterdam)H-Index: 5
#2Sebastiaan Breedveld (EUR: Erasmus University Rotterdam)H-Index: 22
Last. Mischa S. Hoogeman (EUR: Erasmus University Rotterdam)H-Index: 48
view all 5 authors...
Abstract Background /purpose: Intensity-modulated proton therapy (IMPT) is highly sensitive to anatomical variations which can cause inadequate target coverage during treatment. Available mitigation techniques include robust treatment planning and online-adaptive IMPT. This study compares a robust planning strategy to two online-adaptive IMPT strategies to determine the benefit of online adaptation. Materials /Methods: We derived the robustness settings and safety margins needed to yield adequat...
1 CitationsSource
#1Marco Marcello (UWA: University of Western Australia)H-Index: 3
#2James W. Denham (University of Newcastle)H-Index: 56
Last. Martin A. Ebert (UWA: University of Western Australia)H-Index: 26
view all 16 authors...
Abstract Background and purpose This study aimed to identify anatomically-localised regions where planned radiotherapy dose is associated with gastrointestinal toxicities in healthy tissues throughout the pelvic anatomy. Materials and methods Planned dose distributions for up to 657 patients of the Trans Tasman Radiation Oncology Group 03.04 RADAR trial were deformably registered onto a single exemplar computed tomography dataset. Voxel-based multiple comparison permutation dose difference testi...
2 CitationsSource
#1Andrea Bresolin (UniSR: Vita-Salute San Raffaele University)H-Index: 1
Last. Cesare Cozzarini (UniSR: Vita-Salute San Raffaele University)H-Index: 43
view all 20 authors...
Objective. To investigate predictors of patient-reported urinary incontinence (PRUI) in the first 2 years after post-prostatectomy radiotherapy (PORT) with particular emphasis on possible dose-effect relationships. Patients and Methods. Two-hundred-thirteen patients, whose clinical and dosimetric data were prospectively collected within a registered multi-institutional cohort study, underwent PORT with adjuvant (n=106) or salvage (n=107) intent with conventional (n=123, prescribed dose to the pr...
Source